Personalised tumour therapy effectivity tests

General information

Személyre szabott daganatterápiás vizsgálatokBefore applying a targeted cancer therapy, there is a need for molecular genetic testing in order to find the broken genes, which will allow to choice of an efficient active agent.There are also targeted medicines which are uneffective in case a certain genetic mutation is present and hence the transcribed broken protein is also detected int he tumour. You can find more information on our cancer genetic page.

Before applying a targeted cancer therapy, there is a need for molecular genetic testing in order to find the broken genes, which will allow to choice of an efficient active agent.There are also targeted medicines which are uneffective in case a certain genetic mutation is present and hence the transcribed broken protein is also detected int he tumour. You can find more information on our cancer genetic page.

Quality assurance

At PentaCore LAboratory we find it extremely important and essential to validate our internal quality control system regularly and constatnyl with the aid of external specialist institutions. We are proud to present our RAS-Expert Laboratory qualification recieved in 2015 May from one of the most stringent systems for European Pathological Laboratories which can be found at the Ludwig Maximilians University (LMU) in Munich.

This quality assurance system was specifically developed for KRAS and NRAS sequencing and pathological analysis from tumour tissue samples. Europe’s leading pathology laboratories took part in the investigation, where ten unknown samples had to be determined wihtin a short time interval in the double-blinded analysis. Only the best recieved the RAS-Expert Laboratory qualification, based on which our molecular histology results are accepted everywhere expansively by all oncologists, as well as drug companies.



PentaCore Laboratory RAS-Expert qualification certificate:

PentaCore RAS Expert Certificate